Table 2.
Biopsy data, complications, and mortality
| TBLC-procedure characteristics | |
|---|---|
| Biopsy location# | |
| ML, n (%) | 2 (14.2) |
| RLL, n (%) | 125 (88.7) |
| LLL, n (%) | 15 (10.6) |
| Bleeding | 141 (100.0) |
| Minor, n (%) | 118 (83.7) |
| Moderate, n (%) | 23 (16.3) |
| Severe, n (%) | 0 (0.0) |
| Number of biopsies, median (IQR) | 4 (4–4) |
| Biopsy size (mm), median (IQR) | 5 (5–7) |
| Probe size 2.4 mm | 5 (5–7) |
| Probe size 1.9 mm | 5 (4–6) |
| Pneumothorax, n (%) | 21 (14.9) |
| + pleuradrain, n (%) | 14 (9.9) |
| − pleuradrain, n (%) | 7 (5.0) |
| Probe size 2.4 mm, n (%) | 17 (81.0) |
| Probe size 1.9 mm, n (%) | 4 (19.0) |
| Admission, n (%)* | 21 (14.9) |
| Mortality | |
| Procedure related mortality, n (%) | 0 (0.0) |
| 30-days mortality, n/N (%) | 2/141 (1.4) |
| 90-days mortality, n/N (%) | 2/131 (1.5) |
| 1-year mortality, n/N (%) | 4/99 (4.9) |
LLL left lower lobe, ML middle lobe, RLL right lower lobe, TBCL transbronchial lung cryobiopsy
Continuous data expressed as median with inter quartile range (IQR); categorical data as numbers (N) and percentages (%)
#One patient had 2 TBCBs performed in both ML and RLL, respectively, why total N = 142
*Including observation due to e.g. bronchoscopy-related pain or cough